Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2005
09/21/2005EP1577309A1 Optically active dihydropyridine derivative
09/21/2005EP1577302A1 Novel ethylenediamine derivatives
09/21/2005EP1576960A1 Composition containing green and yellow vegetables and light-colored vegetables
09/21/2005EP1576951A1 Formulations for the rectal administration of thrombolytically-active agents
09/21/2005EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use
09/21/2005EP1576088A2 Dominant negative proteins and methods thereof
09/21/2005EP1575976A2 Methods and compositions for therapeutic use of rna interference
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
09/21/2005EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses
09/21/2005EP1575480A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque
09/21/2005EP1450788B1 Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular and/or lymphatic edema
09/21/2005EP1404377B1 Improved chelator conjugates
09/21/2005EP1339694B1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005EP1200115B1 Multi-dose erythropoietin formulations
09/21/2005EP1194174B1 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671744A Low molecular weight oversulfated polysaccharide
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671420A Pegylated factor VII glycoforms
09/21/2005CN1671410A Stabilised solid compositions of factor VII polypeptides
09/21/2005CN1671399A Myocardial perfusion imaging using A2A receptor agonists
09/21/2005CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1669568A Preparation and quality control method of infusion solution for treating obliterative thrombus disease
09/21/2005CN1669476A Novel health food and drink containing marine algae
09/21/2005CN1220060C Process for screening active component from plant extract
09/21/2005CN1219794C Platelet glucoprotein receptor inhibitor, medicinal composition containing same and use thereof
09/21/2005CN1219748C Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines with taurine chloride and glycine chloride
09/21/2005CN1219553C Medicinal film for blood stanching of wound surface and its preparation method
09/21/2005CN1219545C Polygonum capitatum extract and medicinal composition preparation thereof
09/21/2005CN1219511C Method for curing sepsis
09/21/2005CN1219509C Use of rosmarinic acid and derivatives thereof as immunosuppressant or inhibitor of SHz-mediated process
09/20/2005US6946548 Granulocyte colony stimulating factor ("G-CSF") analog polypeptide compositions, related nucleic acids, expression constructs, host cells, and processes for recombinant production of the present G-CSF analogs.
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946489 Substituted biphenyl derivatives
09/20/2005US6946483 Aminoalkenylbenzoyl-benzofuran or benzothiophene, method for preparing same and compositions containing same
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946454 Thio-oxindole derivatives
09/20/2005US6946438 focal cerebral ischemic infarction; plasmin, mini-plasmin (lacking the first four kringles), and micro-plasmin (lacking all five kringles)
09/20/2005US6946279 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same
09/20/2005US6946129 Recombinant anti-CD40 antibody and uses thereof
09/20/2005US6946121 Composition in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
09/20/2005US6945247 Method of treating cardio pulmonary diseases with no group compounds
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/15/2005WO2005085283A1 Modified interleukin-11 and medicinal composition containing the same
09/15/2005WO2005085267A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
09/15/2005WO2005085265A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
09/15/2005WO2005085264A1 Sulfated oligosaccharide derivatives
09/15/2005WO2005085237A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
09/15/2005WO2005085210A1 Nitriles and medicinal compositions containing the same as the active ingredient
09/15/2005WO2005084711A1 A pegylated recombinant erythropoietin that has in vivo activity
09/15/2005WO2005084679A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
09/15/2005WO2005003347A3 Dna-based aptamers for human cathepsin g
09/15/2005US20050203295 NO donor has a nitroso group attached to a tertiary carbon; vascular relaxants, nonsteroidal anti-inflammatory drug; water soluble; potentiated by adding glutathione, use low dosage
09/15/2005US20050203165 Perfectly reproducible crystalline form that especially exhibits valuable characteristics for formulation of inhibitors of angiotensin I converting enzyme; preparation from a solution of the salt in CH2Cl2 or ethyl acetate; treating cardiovascular disease
09/15/2005US20050203127 2-(Phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203094 Thromboembolic disorders; anticoagulants; e.g. 2-[5'-fluoro-2,2'-dihydroxy-5-(2-oxo-tetrahydro-furan-3-yl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050203003 Contulakin-G, analogs thereof and uses therefor
09/15/2005US20050202527 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants
09/15/2005US20050202091 Stable pharmaceutical composition comprising erythropoietin
09/15/2005US20050202027 Multivalent compounds for crosslinking receptors and uses thereof
09/15/2005US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
09/15/2005US20050202007 Determining a P-selectin activity in a biological sample of the subject,increased P-selectin activity in the sample indicates a procoagulant state in the subject
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050199498 Electrophoresis; fibrinogen
09/15/2005DE102004009835A1 New 4-heterocyclyl-benzamide derivatives, useful as antithrombotic agents for treating or preventing e.g. deep vein thrombosis or reocclusion after angioplasty, are inhibitors of factor Xa and other serine proteases
09/15/2005CA2558183A1 Use of enhanced water to improve blood sugar management
09/15/2005CA2557989A1 Sulfated oligosaccharide derivatives
09/15/2005CA2557766A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
09/15/2005CA2557320A1 Fused heterocyclic derivatives for prevention or treatment of hyperglycemia
09/15/2005CA2557270A1 Pyrrole-derivatives as factor xa inhibitors
09/14/2005EP1574504A1 Benzomorpholine derivatives
09/14/2005EP1574219A2 Method of inhibiting fibrosis with a somatostatin agonist
09/14/2005EP1574214A1 Pharmaceutical composition comprising fenofibrate and process for its preparation
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573003A2 Method for producing transgenic animals using oral gene therapy
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572891A2 Bone anti-resorptive compounds
09/14/2005EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572876A2 Transcriptional regulation of target genes
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572243A1 Induction of tolerance through oral administration of a therapeutic agent coupled to a transporting agent
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1404682B1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 671